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Background
Bladder cancer is a common urologic cancer and the 6th
most common cancer in Canada. In terms of malignancy,
this cancer has the highest recurrence rate. The most
common type of bladder cancer is Transitional Cell Carci-
noma (TCC). Worldwide, each year, bladder cancer is
diagnosed in 275,000 people. In the past 10 years, bladder
cancer accounted for 7.5% of all detected cancers in men
and 1.8% of those of women in Canada. More than 2100
deaths per year occur in Canada as a result of bladder
Cancer. Last year, a study at the Vanderbilt University
Medical Center in Nashville illustrated that extended lym-
phadenectomy consistently provided an advantage over
standard approaches at the time of cystectomy with insig-
nificant increases in morbidity. We had similar questions
and decided to do a study to build on current knowledge.
In this report, I am comparing extended and standard
approaches to lymph node removal with respect to com-
plication risks, patient survival outcomes and neoadjuvant
chemotherapy responses.
Methods
In this study, patients were matched by basic informa-
tion (age, BMI, ASA) and pathology characteristics. 75
patients were compared in terms of complications. We
divided these complications into in-hospital (2 weeks or
less), early (2 weeks to 90 days), and late (greater than
90 days). 130 patients were compared in terms of recur-
rence rates and final outcomes: alive with disease, dead
of disease, dead of other cause or no evidence of disease.
Furthermore, analysis was done on patients who
received neoadjuvant chemotherapy and looked at their
final outcomes and recurrence rates as well.
Results
Complications were higher in early and late categories
in the standard type of surgery. However, in-hospital
complications were higher in extended lymphadenect-
omy. Final outcomes showed increased rates of no evi-
dence of disease in extended lymphadenectomy and
lower recurrence rates. Patients who had neoadjuvant
chemotherapy also showed reduced recurrence rates and
more elimination of pathology in the extended group.
Conclusions
Extended lymph node removal (ELNR) illustrates
reduced early and significantly reduced late complication
rates. However, early complications are higher possibly
due to the increased invasiveness of the procedure.
ELNR also demonstrates reduced recurrence rates and
more favorable survival outcomes than the standard
type of surgery. The same positive findings are also seen
in patients who had neoadjuvant chemotherapy.
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